The Relationship Between Tumor Inflammatory Cell Infiltrate and Outcome in Patients with Pancreatic Ductal Adenocarcinoma

被引:58
|
作者
Jamieson, Nigel B. [1 ,2 ]
Mohamed, Mohamed [2 ]
Oien, Karin A. [3 ]
Foulis, Alan K. [3 ]
Dickson, Euan J. [1 ]
Imrie, Clem W. [1 ]
Carter, C. Ross [1 ]
McKay, Colin J. [1 ]
McMillan, Donald C. [2 ]
机构
[1] Glasgow Royal Infirm, W Scotland Pancreat Unit, Glasgow G4 0SF, Lanark, Scotland
[2] Glasgow Royal Infirm, Univ Dept Surg, Glasgow G4 0SF, Lanark, Scotland
[3] Glasgow Royal Infirm, Univ Dept Pathol, Glasgow G4 0SF, Lanark, Scotland
关键词
PROGNOSTIC VALUE; SYSTEMIC INFLAMMATION; CURATIVE RESECTION; T-CELLS; CANCER; SURVIVAL; LYMPHOCYTES; CACHEXIA; SCORE; MANAGEMENT;
D O I
10.1245/s10434-012-2370-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The tumor-associated inflammatory cell infiltrate is recognized to have prognostic value in various common solid tumors. However, the prognostic value of the tumor inflammatory cell infiltrate has not been established in pancreatic ductal adenocarcinoma (PDAC) nor has its relationship with the systemic inflammatory response. Retrospective study was made of 173 patients who underwent surgery between 1997 and 2009. Routine pathology specimens were scored according to density of the tumor inflammatory cell infiltrate, and biochemical data were collected preoperatively. Low-grade tumor inflammatory cell infiltrate was associated with earlier tumor recurrence (P < 0.001) and particularly in the liver (P = 0.027). It was also associated with T3 tumors (P < 0.05), lymph node involvement (P < 0.05), and resection margin involvement (P < 0.05). On univariate survival analysis, age < 65 years (P < 0.05), mGPS (P < 0.001), increased tumor stage (P < 0.01), nodal involvement (P < 0.01), size (P < 0.05), grade (P < 0.05), perineural invasion (P < 0.05), venous invasion (P < 0.01), resection margin involvement (P a parts per thousand currency sign 0.001), vascular reconstruction (P < 0.05), and no adjuvant chemotherapy (P < 0.05) were associated with poor survival. In contrast, high-grade tumor inflammatory cell infiltrate was associated with better survival (P < 0.001). On multivariate survival analysis, mGPS [hazard ratio (HR): 1.77, 95 % confidence interval (95 % CI): 1.19-2.62, P = 0.005], tumor stage (HR: 2.21, 95 % CI: 1.16-4.23, P = 0.016), resection margin involvement (HR: 2.19, 95 % CI: 1.41-3.44, P = 0.001), venous invasion (HR: 1.79, 95 % CI: 1.22-2.63, P = 0.003), tumor inflammatory cell infiltrate (HR: 0.37, 95 % CI: 0.25-0.55, P = 0.0001), and adjuvant chemotherapy (P = 0.04) were independently prognostic. The results of the study show, for the first time, that the presence of a high-grade tumor inflammatory cell infiltrate is an independent predictor of prolonged overall survival following resection for PDAC. Furthermore, measures of the local and the systemic inflammatory response were inversely associated.
引用
收藏
页码:3581 / 3590
页数:10
相关论文
共 50 条
  • [31] Detection of circulating tumor cells in blood of pancreatic ductal adenocarcinoma patients
    Mayado, Andrea
    Orfao, Alberto
    Mentink, Anouk
    Laura Gutierrez, Maria
    Munoz-Bellvis, Luis
    Terstappen, Leon W. M. M.
    CANCER DRUG RESISTANCE, 2020, 3 (01) : 83 - 97
  • [32] Haptoglobin is elevated in serum and tumor from pancreatic ductal adenocarcinoma patients
    Firpo, MA
    Granger, SR
    Dai, Q
    Boucher, KM
    Scaife, C
    Bauer, AR
    Mulvihill, SJ
    GASTROENTEROLOGY, 2005, 128 (04) : A531 - A531
  • [33] Prognostic significance of circulating tumor microemboli in patients with pancreatic ductal adenocarcinoma
    Wu, Guangdong
    Zhu, Rongrong
    Li, Yatong
    Zhao, Yupei
    Dai, Menghua
    ONCOLOGY LETTERS, 2018, 15 (05) : 7376 - 7382
  • [34] Importance of triple tumor markers as biomarkers in patients with pancreatic ductal adenocarcinoma
    Takagi, Tadataka
    Nagai, Minako
    Nishiwada, Satoshi
    Terai, Taichi
    Yasuda, Satoshi
    Matsuo, Yasuko
    Doi, Shunsuke
    Kohara, Yuichiro
    Sho, Masayuki
    ANNALS OF GASTROENTEROLOGICAL SURGERY, 2023, 7 (02): : 326 - 335
  • [35] Targeting the tumor microenvironment in pancreatic ductal adenocarcinoma
    Pandey, Veethika
    Storz, Peter
    EXPERT REVIEW OF ANTICANCER THERAPY, 2019, 19 (06) : 473 - 482
  • [36] Panoramic tumor microenvironment in pancreatic ductal adenocarcinoma
    Li, Xiaoying
    Hou, Wanting
    Xiao, Chaoxin
    Yang, Heqi
    Zhao, Chengjian
    Cao, Dan
    CELLULAR ONCOLOGY, 2024, 47 (05) : 1561 - 1578
  • [37] Tumor Recurrence Is Independent of Pancreatic Fistula in Patients after Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma
    Assifi, M. Mura
    Zhang, Sarah
    Leiby, Benjamin E.
    Pequignot, Edward C.
    Xia, Brent
    Rosato, Ernest
    Lavu, Harish
    Kennedy, Eugene P.
    Yeo, Charles J.
    Berger, Adam C.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2013, 217 (04) : 621 - 627
  • [38] Pancreatic ductal adenocarcinoma in young patients
    Pernick, NL
    Eldean, ZS
    Kabbani, W
    Philip, P
    Shields, A
    Vaitkevicius, V
    Adsay, NV
    LABORATORY INVESTIGATION, 2001, 81 (01) : 201A - 201A
  • [39] Pancreatic ductal adenocarcinoma in young patients
    Pernick, NL
    Eldean, ZS
    Kabbani, W
    Philip, P
    Shields, A
    Vaitkevicius, V
    Adsay, NV
    MODERN PATHOLOGY, 2001, 14 (01) : 201A - 201A
  • [40] RELATIONSHIP ANALYSIS BETWEEN HUMAN ABO BLOOD GROUP AND PANCREATIC DUCTAL ADENOCARCINOMA
    Wang Lianmin
    Shi Yanmei
    Tang Zhiyi
    Liu Yaqiong
    He Haiyu
    Wang Tao
    Su Kun
    Wang Kun
    Chang Jiang
    Wu Tao
    ACTA MEDICA MEDITERRANEA, 2022, 38 (01): : 377 - 381